| Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, operating profit, depreciation and amortization, interest expense, and assets for the years ended November 30, 2024 and November 30, 2023:
|
|
|
|
|
|
|
|
|
|
|
For the years ended November 30, |
|
|
|
2024 |
|
|
2023 |
|
Net revenue: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
31,551,550 |
|
|
$ |
30,796,091 |
|
PrepaCyte CB |
|
|
67,884 |
|
|
|
66,456 |
|
Public cord blood banking |
|
|
366,672 |
|
|
|
481,148 |
|
Total net revenue |
|
$ |
31,986,106 |
|
|
$ |
31,343,695 |
|
Cost of sales: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
6,889,882 |
|
|
$ |
7,216,877 |
|
PrepaCyte CB |
|
|
45,082 |
|
|
|
35,490 |
|
Public cord blood banking |
|
|
1,012,788 |
|
|
|
1,138,096 |
|
Total cost of sales |
|
$ |
7,947,752 |
|
|
$ |
8,390,463 |
|
Operating profit: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
4,131,796 |
|
|
$ |
(7,911,698 |
) |
PrepaCyte CB |
|
|
(4,976 |
) |
|
|
3,188 |
|
Public cord blood banking |
|
|
(646,536 |
) |
|
|
(4,395,522 |
) |
Total operating profit (loss) |
|
$ |
3,480,284 |
|
|
$ |
(12,304,032 |
) |
Depreciation and amortization: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
455,324 |
|
|
$ |
1,095,009 |
|
PrepaCyte CB |
|
|
27,778 |
|
|
|
27,778 |
|
Public cord blood banking |
|
|
420 |
|
|
|
1,441 |
|
Total depreciation and amortization |
|
$ |
483,522 |
|
|
$ |
1,124,228 |
|
Interest expense: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,864,684 |
|
|
$ |
1,236,794 |
|
PrepaCyte CB |
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
Total interest expense |
|
$ |
1,864,684 |
|
|
$ |
1,236,794 |
|
The following table shows the assets by segment as of November 30, 2024 and November 30, 2023:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
|
November 30, 2024 |
|
|
November 30, 2023 |
|
Assets: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell
service |
|
$ |
59,259,451 |
|
|
$ |
55,471,149 |
|
PrepaCyte CB |
|
|
138,169 |
|
|
|
148,040 |
|
Public cord blood banking |
|
|
5,280,013 |
|
|
|
5,601,581 |
|
Total assets |
|
$ |
64,677,633 |
|
|
$ |
61,220,770 |
|
|